Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 10Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Endometrial Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Cardiovascular Diseases 3Cardiotoxicity 3Rectal Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Non-Hodgkin 2Leukemia 2Kidney Neoplasms 2Heart Failure 2Head and Neck Neoplasms 2Glioblastoma 2Endometrial Hyperplasia 2Carcinoma, Renal Cell 2Waldenstrom Macroglobulinemia 1Venous Thrombosis 1Urogenital Neoplasms 1Smoking 1

Interventions

etrolizumab 5Infliximab 4Adalimumab 4golimumab 3Nivolumab 3Specimen Handling 2Colonoscopy 2CT-P13 2pembrolizumab 1peficitinib 1cabozantinib 1Vitamin E 1Sutures 1Surgical Instruments 1Ringer's Lactate 1Proctectomy 1Pneumococcal Vaccines 1Platinum Compounds 1Papillomavirus Vaccines 1Narrow Band Imaging 1NX-13 1Methylprednisolone 1Mesalamine 1Medical Marijuana 1Lysine Acetyltransferase 5 1Loperamide 1Iron-Dextran Complex 1Ipilimumab 1Injections 1Indigo Carmine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Colitis, Ulcerative × Atorvastatin × Clear all
NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Northwestern University

Phase 2 Active not recruiting
42 enrolled
Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡